Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily
Clinical trial NCT02549469 · COMPLETED
Trial details
- NCT number
- NCT02549469
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.